A. Heller et al., Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug, J PHARM EXP, 298(2), 2001, pp. 769-779
Citations number
41
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Methamphetamine use by females of child-bearing age has become a major publ
ic health concern in terms of the long-term risk to the exposed fetus. We e
xamined the possibility of enhanced adult neurotoxic potential of the drug
in offspring that had been exposed to methamphetamine in utero during gesta
tional days 7 to 18. While basal levels of monoamines were not affected by
prenatal exposure to methamphetamine, we observed an enhanced neurotoxicity
in adult male offspring following drug challenge with effects localized pr
imarily to the dopaminergic nigrostriatal projection. This was evidenced by
greater methamphetamine-induced reductions of dopaminergic markers in the
striatum [dopamine (DA), dihydroxyphenylacetic acid, homovanillic acid (HVA
), and 3-methoxytyramine (3-MT)] and ventral brainstem (DA) of prenatal met
hamphetamine-treated males compared with saline-treated animals. Some effec
ts of prenatal methamphetamine exposure were observed in female offspring,
but these were limited to striatal levels of 3-MT and HVA. Differential gen
der sensitivity to the neurotoxic effect of methamphetamine was shown to be
correlated with hyperthermic response. Hyperthermic effects, however, do n
ot account for the increased susceptibility of prenatal methamphetamine-tre
ated males to drug-induced striatal DA neurotoxicity since methamphetamine
challenge did not evoke a significantly greater hyperthermic response in th
ese animals compared with prenatal saline-treated males. The findings raise
the concern that male methamphetamine abusers may be at risk for an enhanc
ed neurotoxic risk if they were exposed to the drug in utero.